Brief by Shorts91 Newsdesk / 05:40am on 26 Sep 2025,Friday Business
President Trump announced 100% tariffs on all branded or patented pharmaceutical products starting October 1, 2025, unless companies build manufacturing plants in the US. Indian pharmaceutical giants faced sharp declines Friday morning as Cipla dropped 1.91%, Sun Pharma fell 3%, Dr Reddy's declined 1.50%, and Zydus Lifesciences plunged 3.22%. Alkem Laboratories also dropped 2.26%. The Nifty Pharma index fell 1.40% to 21,669.80 points. The tariff announcement particularly impacts Indian firms who supply affordable generics covering nine out of ten US prescriptions. This move threatens both manufacturers' revenues and low-cost medicine availability in America, as the US imported nearly $233 billion worth of pharmaceutical products in 2024. (PC: X & Getty Images)
